← All trials
NCT06796907
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 4, 2025
- Primary completion
- Dec 17, 2027
- Completion date
- Apr 5, 2028
- First posted
- Jan 28, 2025
- Last posted
- Oct 14, 2025
- Enrollment
- 392
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- GlaxoSmithKlineLead sponsor
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.